Please use this identifier to cite or link to this item: http://bura.brunel.ac.uk/handle/2438/32626
Title: Agreement testing of AMSTAR-PF, a tool for quality appraisal of systematic reviews of prognostic factor studies
Authors: Henry, ML
O'Connell, NE
Riley, RD
Moons, KGM
Shea, BJ
Hooft, L
Wallwork, SB
Damen, JAA
Skoetz, N
Appiah, RP
Berryman, C
Crouch, SM
Ferencz, GA
Grant, AR
Henry, KM
Herman, AM
Karran, EL
Koralegedera, I
Leake, HB
MacIntyre, E
Mouatt, B
Phuentso, K
Van Der Laan, DA
Welsby, E
Wiles, LK
Wilkinson, EM
Wilson, MK
Wilson, MV
Moseley, GL
Issue Date: 27-Jan-2026
Publisher: BMJ Publishing Group
Citation: Henry, M.L. et al. (2026) 'Agreement testing of AMSTAR-PF, a tool for quality appraisal of systematic reviews of prognostic factor studies', BMJ Open, 16, e109388, pp. 1 - 12. doi: 10.1136/bmjopen-2025-109388.
Abstract: Objectives: To test the agreement and usability of a novel quality appraisal tool: A MeaSurement Tool to Assess systematic Reviews of Prognostic Factor studies (AMSTAR-PF). Design: Observational study. Participants: 14 appraisers of varied experience levels and backgrounds, including undergraduate, master’s and PhD students, postgraduate researchers, research fellows and clinicians. Study procedure: Eight systematic reviews were rated by all reviewers using AMSTAR-PF. Outcome measures: Planned measures included intrapair and inter-pair agreement using Cohen’s and Fleiss’ kappa, time of use and time to reach consensus. Interrater agreement was an added measure, and Gwet’s agreement coefficient was calculated and presented due to its greater stability across agreement levels. The percentage of intrapair agreements identical or one category apart was also presented. Results: Interrater agreement averaged 0.59 (range 0.21–0.90), inter-pair agreement 0.61 (range 0.24–0.91) and intrapair agreement 0.75 (range 0.45–0.95) across the domains, with agreement for the overall rating 0.46 (95% CI 0.30 to 0.62) for interrater agreement, 0.46 (95% CI 0.17 to 0.74) for inter-pair agreement and 0.68 (range of averages 0.22–1.00) for intrapair agreement. The majority (60.7%) of intrapair ratings were identical, with 94.6% of final ratings either identical or only one category different for the overall appraisal. The time taken to appraise a study with AMSTAR-PF improved with use and averaged around 34 min after the first two appraisals. Conclusions: Despite some variance in agreement for different domains and between different appraisers, the testing results suggest that AMSTAR-PF has clear utility for appraising the quality of systematic reviews of prognostic factor studies.
Description: Strengths And Limitations Of This Study: ⇒ The testing protocol was preregistered and standardised across all appraisers. ⇒ The 14 appraisers, who had varying levels of experience, tested A MeaSurement Tool to Assess systematic Reviews of Prognostic Factor studies on eight articles covering a range of topics. ⇒ Gwet’s agreement coefficient and kappa values were calculated across interrater, inter- pair and intrapair agreement, and time of use and time to consensus were recorded. ⇒ Appraisers had limited experience in prognostic factor research and reviews were often outside their expertise.
Data availability statement: Data are available upon reasonable request.
A preprint version of the article is available on MedRxiv at https://doi.org/10.1101/2025.04.10.25325555 and has not been certified by peer review. It reports new medical research that has yet to be evaluated and so should not be used to guide clinical practice.
URI: https://bura.brunel.ac.uk/handle/2438/32626
ISSN: 2044-6055
Other Identifiers: ORCiD: Michael L. Henry https://orcid.org/0000-0003-2871-6695
ORCiD: Neil E. O’Connell https://orcid.org/0000-0003-1989-4537
ORCiD: Richard D. Riley https://orcid.org/0000-0001-8699-0735
ORCiD: Karel G. M. Moons https://orcid.org/0000-0003-2118-004X
ORCiD: Lotty Hooft https://orcid.org/0000-0002-7950-2980
ORCiD: Johanna A. A. Damen https://orcid.org/0000-0001-7401-4593
ORCiD: Nicole Skoetz https://orcid.org/0000-0003-4744-6192
ORCiD: R. P. Appiah https://orcid.org/0009-0000-8354-350X
ORCiD: S. M. Crouch https://orcid.org/0009-0008-8114-5135
ORCiD: G. A. Ferencz https://orcid.org/0009-0008-2379-8429
ORCiD: E. L. Karran https://orcid.org/0000-0002-6088-8289
ORCiD: I. Koralegedera https://orcid.org/0000-0002-7544-4883
ORCiD: A. M. Herman https://orcid.org/0000-0002-3338-0543
ORCiD: H. B. Leake https://orcid.org/0000-0002-6133-2186
ORCiD: E. MacIntyre https://orcid.org/0000-0003-3556-233X
ORCiD: B. Mouatt https://orcid.org/0000-0003-2422-1599
ORCiD: K. Phuentso https://orcid.org/0000-0003-4847-382X
ORCiD: D. A. Van Der Laan https://orcid.org/0009-0009-4748-0607
ORCiD: E. Welsby https://orcid.org/0000-0002-9901-7800
ORCiD: L. K. Wiles https://orcid.org/0000-0002-6557-6196
ORCiD: E. M. Wilkinson https://orcid.org/0000-0002-0656-8495
ORCiD: M .K. Wilson https://orcid.org/000-0002-4552-1219
ORCiD: Monique V. Wilson https://orcid.org/0000-0003-3987-8438
Appears in Collections:Department of Health Sciences Research Papers

Files in This Item:
File Description SizeFormat 
FullText.pdfCopyright information: © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Published by BMJ Group. This is an open access article distributed in accordance with the Creative Commons Attribution 4.0 International (CC BY 4.0) license, which permits others to copy, redistribute, remix, transform and build upon this work for any purpose, provided the original work is properly cited, a link to the licence is given, and indication of whether changes were made. See: https://creativecommons.org/licenses/by/4.0/.1.62 MBAdobe PDFView/Open
Supplementary.pdfCopyright information: © Author(s) (or their employer(s)) 2026. Re-use permitted under CC BY. Supplemental material: This content has been supplied by the author(s). It has not been vetted by BMJ Publishing Group Limited (BMJ) and may not have been peer-reviewed. Any opinions or recommendations discussed are solely those of the author(s) and are not endorsed by BMJ. BMJ disclaims all liability and responsibility arising from any reliance placed on the content. Where the content includes any translated material, BMJ does not warrant the accuracy and reliability of the translations (including but not limited to local regulations, clinical guidelines, terminology, drug names and drug dosages), and is not responsible for any error and/or omissions arising from translation and adaptation or otherwise.430.44 kBAdobe PDFView/Open


This item is licensed under a Creative Commons License Creative Commons